Document Detail

Olmesartan and intestinal adverse effects in the ROADMAP study.
MedLine Citation:
PMID:  23218089     Owner:  NLM     Status:  MEDLINE    
Jan Menne; Hermann Haller
Related Documents :
11419739 - Simultaneous determination of taxol and its metabolites in microsomal samples by a simp...
23791159 - Bovine colostrum improves intestinal function following formula-induced gut inflammatio...
3184259 - Zearanol metabolism by subcellular fractions from lamb liver.
1473229 - Metabolism of 1- and 2-naphthylamine in isolated rat hepatocytes.
5442709 - Delta-1-tetrahydrocannabinol: structure of a major metabolite.
21639889 - Analysis of complex metabolic behavior through pathway decomposition.
4328819 - Comparative metabolism and selectivity of organophosphate and carbamate insecticides.
6701909 - Impaired in vitro metabolism of the flukicidal agent nitroxynil by hepatic microsomal c...
7169039 - Biochemical bases for environmental adaptation in goldfish (carassius auratus l.): resi...
Publication Detail:
Type:  Comment; Letter    
Journal Detail:
Title:  Mayo Clinic proceedings     Volume:  87     ISSN:  1942-5546     ISO Abbreviation:  Mayo Clin. Proc.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-11     Completed Date:  2013-03-12     Revised Date:  2013-12-13    
Medline Journal Info:
Nlm Unique ID:  0405543     Medline TA:  Mayo Clin Proc     Country:  England    
Other Details:
Languages:  eng     Pagination:  1230-1; author reply 1232     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin II Type 1 Receptor Blockers / adverse effects*
Diarrhea / chemically induced*
Imidazoles / adverse effects*
Intestines / pathology*
Stomach / pathology*
Tetrazoles / adverse effects*
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 0/Imidazoles; 0/Tetrazoles
Comment On:
Mayo Clin Proc. 2012 Aug;87(8):732-8   [PMID:  22728033 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score.
Next Document:  Defining the epidemiology of bloodstream infections: the 'gold standard' of population-based assessm...